All 150 foods

Food detail

029 / 150Whole grains

Barley

Audited source card available

View my plan

The short answer

Adds beta-glucan-rich soluble fiber and a chewy whole-grain option to meals.

Evidence and scope
Food context; study findings do not grade the whole food.
Important limitation
Trials support effects on LDL cholesterol and post-meal glucose when enough barley beta-glucan is consumed.
Before deciding
Benefits depend on the edible form and preparation. Added sugar, sodium, refined flour, or deep-frying can change the nutritional profile.

01 / NUTRIENTS & FORM

Nutrient snapshot

The exact food form matters. Raw, cooked, drained, dried, fortified, and branded versions can have meaningfully different values.

What the current food record supports

Adds beta-glucan-rich soluble fiber and a chewy whole-grain option to meals.

Fiber & gutHeart patternGlycemic quality
Quantitative profile awaiting an audited source match

We have not assigned a specific composition record to this food yet. Values will appear only after the food description, preparation state, edible portion, and serving weight are verified.

How nutrient values will be verified
Planned display basis
Practical serving and per 100 g
Planned nutrient fields
Energy, protein, carbohydrate, fiber, fat, sodium, and the most relevant micronutrients
Publication rule
Show the database, record ID, food form, serving weight, and verification date

02 / RESEARCH

Evidence map: baseline and emerging signals

The current baseline stays visually separate from credible findings that are mechanistic, responder-dependent, small, or not yet replicated.

Established / currently defensibleTrials support effects on LDL cholesterol and post-meal glucose when enough barley beta-glucan is consumed.

The general interpretation that does not depend on one unreplicated positive result. An established limitation is as important as an established benefit.

Audited evidence anchorQualified finding
PMID 27273067

A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction i-iv .

The abstract reports a qualified or outcome-specific signal. It does not establish a general health benefit beyond the tested form, population, comparator, and duration.

Study design
Systematic review and meta-analysis
Tested form / scope
Extract, protein, or isolated component
Editorial interpretation
Trials support effects on LDL cholesterol and post-meal glucose when enough barley beta-glucan is consumed.
Screening record
One relevant human PubMed source was verified and classified. This is a source card, not a complete evidence synthesis or a count of favorable studies.
Run bounded PubMed discovery search

Educational information only—not medical advice. Allergies, medicines, pregnancy, kidney disease, diabetes treatment, swallowing needs, and preparation safety can change what is appropriate.